- Revenue of
$8.4 million , up 14.1% year-over-year - Gross profit margin of 76.3%, up 71 bps year-over-year
- Net income of
$910,000 , up 341% year-over-year - Generated positive cash from operations of
$1.2 million fiscal year-to-date - Peaks, the company’s telemedicine platform, surpasses
$2.0 million in revenue in less than a year, scaling from$248,000 into a high-margin growth platform - Reduced outstanding shares of common stock by 3.6% year over year through share repurchases
- Geographic expansion underway with up to 10 additional state licenses pending
- Strong calendar 2026 performance signals positive trajectory for fiscal Q4
“We exited the third fiscal quarter with strong strategic momentum and continued progress across our diversified platform,” said
Fiscal Q3 2026 Key Financial Highlights
- Revenue of
$8.4 million , up 14.1% compared to$7.4 million for the three months endedDecember 31, 2024 - Gross profit of
$6.4 million , or a gross margin of 76.3%, as compared to$5.1 million or a gross margin of 69.2%, for the three months endedDecember 31, 2024 , an increase of$1.3 million , or 25.8% on a dollar basis - Net Income of
$910,000 , up 341.0% compared to$206,000 for the three months endedDecember 31, 2024 - Total Assets of
$8.1 million , up 14.5% compared to$7.1 million atMarch 31, 2025 - Repurchased and retired 3,703,296 shares of common stock for the nine months ended
December 31, 2025
Third Fiscal Quarter 2026 Financial Results
Revenue
Revenue for the three months ended
Gross Profit/Margin
Gross profit for the third quarter of fiscal 2026 was
Operating Expenses
For the three months ended
Net Income
Net income was
Adjusted EBITDA
Adjusted EBITDA was
Balance Sheet
As of
The Company repurchased and retired 1,143,000 and 3,703,296 shares of its common stock for the three and nine months ended
Conference Call and Webcast:
The Company will host a conference call and webcast to discuss its second fiscal quarter results, highlights, and outlook at
Conference Call Information
Date:
Time:
Toll Free: 1 800-450-7155 Code: 9041018#
International: +1 857-999-9155 Code: 9041018#
Live Webcast Link: https://www.cstproxy.com/earthsciencetech/earnings/2025/q3/
Conference Call Replay Information
Replay Webcast Link: https://www.cstproxy.com/earthsciencetech/earnings/2025/q3/
Non-GAAP Measures
In addition to disclosing financial results in accordance with accounting principles generally accepted in
Please refer to “Reconciliation of Non-GAAP Measures” in this document for a detailed explanation of the adjustments made to the comparable
About
Beyond healthcare, ETST manages Avenvi, its real estate and asset management arm, and 80% of MagneChef, a direct-to-consumer brand leveraging proprietary IP for innovative kitchen products. The Company is also committed to social responsibility through the
To learn more, please visit: www.EarthScienceTech.com
Forward-Looking Statements
Except for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.
Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,” “forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
Contact:
Hayden IR
James Carbonara
(646)-755-7412
james@haydenir.com
(646) 536-7331
brett@haydenir.com
-- Tables Follow --
Consolidated Balance Sheets
(Unaudited)
| As of | As of | |||||||
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | 415,699 | $ | 1,473,228 | ||||
| Accounts Receivable | 306,118 | 129,064 | ||||||
| Equity Investments at fair value | 1,126,307 | 645,438 | ||||||
| Inventory | 1,088,019 | 503,938 | ||||||
| Deposits | 57,631 | 338,108 | ||||||
| Prepaid | 39,159 | 20,730 | ||||||
| Total current assets | 3,032,933 | 3,110,505 | ||||||
| Non-Current Assets: | ||||||||
| Property and Equipment, net | 1,890,801 | 1,384,110 | ||||||
| Right of use asset, net | 139,231 | 172,429 | ||||||
| 2,648,788 | 2,302,792 | |||||||
| Intangible Assets, net | 377,684 | 96,885 | ||||||
| Total Assets | $ | 8,089,437 | $ | 7,066,721 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Accounts payable | $ | 1,088,521 | $ | 492,352 | ||||
| Accrued expenses and other payable | 1,019,036 | 2,322,022 | ||||||
| Current portion of operating lease obligations | 121,851 | 121,851 | ||||||
| Current portion of equipment loan | 30,592 | 30,592 | ||||||
| Short-term business loan | - | 179,488 | ||||||
| Total Current Liabilities | 2,260,000 | 3,146,305 | ||||||
| Long-Term Liabilities: | ||||||||
| Lease liability less current maturities | 18,177 | 37,878 | ||||||
| Equipment loan, non-current | 8,254 | 31,427 | ||||||
| Total Liabilities | 2,286,431 | 3,215,610 | ||||||
| Commitment and Contingencies (Note 11) | ||||||||
| Stockholders’ Equity: | ||||||||
| Preferred stock, par value | 1,000 | 1,000 | ||||||
| Common stock, par value | 291,644 | 295,348 | ||||||
| Additional paid-in capital | 30,836,759 | 31,480,143 | ||||||
| Accumulated deficit | (25,396,738 | ) | (27,738,975 | ) | ||||
| Treasury Stock, at cost 35,000 and 1,045,296 shares as of | (5,525 | ) | (186,404 | ) | ||||
| Non-Controlling Interest | 75,866 | - | ||||||
| Total stockholders’ Equity | 5,803,006 | 3,851,111 | ||||||
| Total Liabilities and Equity | $ | 8,089,437 | $ | 7,066,721 | ||||
Consolidated Statements of Operations
For Three and Nine months ended
(Unaudited)
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Revenue | $ | 8,386,779 | 7,352,635 | $ | 26,197,596 | $ | 24,440,600 | |||||||||
| Cost of Goods Sold | 1,987,769 | 2,265,762 | 6,983,827 | 6,676,612 | ||||||||||||
| Gross Profit | 6,399,010 | 5,086,873 | 19,213,769 | 17,763,988 | ||||||||||||
| Expenses | ||||||||||||||||
| Salaries Expense | 2,931,244 | 3,297,826 | 10,787,357 | 10,372,308 | ||||||||||||
| Office/Selling, General and Administrative Expenses | 914,029 | 809,850 | 2,741,912 | 3,455,474 | ||||||||||||
| Advertising & marketing | 708,511 | 346,109 | 2,082,463 | 511,455 | ||||||||||||
| Bank charges | 250,332 | 210,549 | 725,340 | 770,849 | ||||||||||||
| Legal & Professional Fees | 56,022 | 61,540 | 138,141 | 243,245 | ||||||||||||
| Insurance | 40,318 | 79,569 | 126,863 | 160,395 | ||||||||||||
| Depreciation and Amortization | 121,790 | 44,778 | 342,751 | 108,201 | ||||||||||||
| Utilities | 34,743 | 10,426 | 102,769 | 21,257 | ||||||||||||
| Total Expenses | 5,056,988 | 4,860,647 | 17,047,597 | 15,643,184 | ||||||||||||
| Other Income/Expenses | ||||||||||||||||
| Dividend Income | 4,537 | 9,123 | 13,944 | 9,123 | ||||||||||||
| Interest earned | 457 | 16 | 2,259 | 13,216 | ||||||||||||
| Net realized gain on sale of investments | 309,807 | 174,613 | 536,951 | 174,613 | ||||||||||||
| Unrealized Gain/Loss of fair value changes of investments | (613,741 | ) | (197,277 | ) | (262,067 | ) | (197,277 | ) | ||||||||
| Interest Expenses | (4,769 | ) | (6,290 | ) | (16,335 | ) | (11,097 | ) | ||||||||
| Net Income before taxes | 1,038,314 | 206,411 | 2,440,925 | 2,109,382 | ||||||||||||
| Income Tax | 127,946 | - | 127,946 | 28,349 | ||||||||||||
| Net Income | 910,367 | 206,411 | 2,312,978 | 2081,033 | ||||||||||||
| Net Income/(Loss) attributed to non-controlling interest | (9 | ) | - | (29,250 | ) | - | ||||||||||
| Net Income attributed to shareholders | 910,376 | 206,411 | 2,342,237 | 2,081,382 | ||||||||||||
| Net Income per common share-Basic and Diluted | 0.003 | 0.001 | 0.008 | 0.007 | ||||||||||||
| Weighted average number of common shares outstanding basic and diluted | 292,804,167 | 302,885,823 | 293,564,655 | 306,278,649 | ||||||||||||
Source: